Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL1998431

NCC(=O)NCC1CC1.O=C(O)C(F)(F)F

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.47
CYP2D6 P10635 1/20 0.42
ARG1 P05089 1/20 0.41
HDAC6 Q9UBN7 3/20 0.38
MLYCD O95822 1/20 0.38
ALDH1A1 P00352 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C19 P33261 1/20 0.36
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC1 Q13547 1/20 0.35
AVPR1B P47901 1/20 0.35
F2 P00734 2/20 0.34
PRSS1 P07477 1/20 0.34
EPHX1 P07099 1/20 0.34
FAAH O00519 1/20 0.34
KDM4E B2RXH2 1/20 0.34
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1380295 0.87
Trifluoroacetic Acid SCHEMBL5348233 0.82 TDP1 (0.42) TDP1HDAC6MLYCDALDH1A1CYP3A4
Trifluoroacetic Acid SCHEMBL21813736 0.81 CYP2D6 (0.52) TDP1CYP2D6HDAC6MLYCDALDH1A1
SCHEMBL8601731 0.80 PLG (0.57) TDP1CYP2D6ARG1ALDH1A1EPHX1
SCHEMBL9795157 0.79 TDP1 (0.52) TDP1CYP2D6ARG1ALDH1A1CYP3A4
SCHEMBL9795153 0.79 TDP1 (0.52) TDP1CYP2D6ARG1ALDH1A1CYP3A4
Hydrochloric Acid SCHEMBL8117093 0.79 PLG (0.55) TDP1CYP2D6ARG1ALDH1A1EPHX1
Trifluoroacetic Acid SCHEMBL6510018 0.79 TDP1 (0.52) TDP1CYP2D6HDAC6MLYCDALDH1A1
SCHEMBL18235911 0.78 TDP1 (0.50) TDP1CYP2D6ARG1ALDH1A1CYP3A4
SCHEMBL10702291 0.77 CYP2D6 (0.61) TDP1CYP2D6ALDH1A1EPHX1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7960560-B2 1-(biphenyl-4-ylmethyl)imidazolidine-2,4-dione N.V. ORGANON (NL) 2011-06-14 US disclosed
US-20100144723-A1 1-(BIPHENYL-4-YLMETHYL)IMIDAZOLIDINE-2,4-DIONE N. V. ORGANON 2010-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100144723-A1 1-(BIPHENYL-4-YLMETHYL)IMIDAZOLIDINE-2,4-DIONE OPRM1, OR10J3, OPRD1 TDP1 2858/4885CYP2D6 452/4885ARG1 407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.